Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease
- PMID: 30602367
- PMCID: PMC6317198
- DOI: 10.1186/s12967-018-1756-4
Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease
Abstract
Dysbiosis represents changes in composition and structure of the gut microbiome community (microbiome), which may dictate the physiological phenotype (health or disease). Recent technological advances and efforts in metagenomic and metabolomic analyses have led to a dramatical growth in our understanding of microbiome, but still, the mechanisms underlying gut microbiome-host interactions in healthy or diseased state remain elusive and their elucidation is in infancy. Disruption of the normal gut microbiota may lead to intestinal dysbiosis, intestinal barrier dysfunction, and bacterial translocation. Excessive uremic toxins are produced as a result of gut microbiota alteration, including indoxyl sulphate, p-cresyl sulphate, and trimethylamine-N-oxide, all implicated in the variant processes of kidney diseases development. This review focuses on the pathogenic association between gut microbiota and kidney diseases (the gut-kidney axis), covering CKD, IgA nephropathy, nephrolithiasis, hypertension, acute kidney injury, hemodialysis and peritoneal dialysis in clinic. Targeted interventions including probiotic, prebiotic and symbiotic measures are discussed for their potential of re-establishing symbiosis, and more effective strategies for the treatment of kidney diseases patients are suggested. The novel insights into the dysbiosis of the gut microbiota in kidney diseases are helpful to develop novel therapeutic strategies for preventing or attenuating kidney diseases and complications.
Keywords: Gut microbiota; Kidney diseases; Metabolome; Microbiome; Probiotics.
Figures



Similar articles
-
The impact of gut microbiota on kidney function and pathogenesis.Biomed Pharmacother. 2017 Sep;93:412-419. doi: 10.1016/j.biopha.2017.06.066. Epub 2017 Jun 24. Biomed Pharmacother. 2017. PMID: 28654798 Review.
-
Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.Pflugers Arch. 2020 Mar;472(3):303-320. doi: 10.1007/s00424-020-02352-x. Epub 2020 Feb 17. Pflugers Arch. 2020. PMID: 32064574 Review.
-
Gut microbiome and kidney disease: a bidirectional relationship.Pediatr Nephrol. 2017 Jun;32(6):921-931. doi: 10.1007/s00467-016-3392-7. Epub 2016 Apr 29. Pediatr Nephrol. 2017. PMID: 27129691 Free PMC article. Review.
-
Role of the Gut Microbiota in Children with Kidney Disease.Children (Basel). 2023 Jan 31;10(2):269. doi: 10.3390/children10020269. Children (Basel). 2023. PMID: 36832398 Free PMC article.
-
The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.Clin Exp Nephrol. 2017 Feb;21(1):7-15. doi: 10.1007/s10157-016-1255-y. Epub 2016 Mar 10. Clin Exp Nephrol. 2017. PMID: 26965149 Review.
Cited by
-
A child with abdominal pain, arthralgia, palpable skin rash, hepatosplenomegaly, and pancytopenia: Answers.Pediatr Nephrol. 2023 Jun;38(6):1771-1773. doi: 10.1007/s00467-022-05750-8. Epub 2022 Oct 6. Pediatr Nephrol. 2023. PMID: 36203105 No abstract available.
-
Bacteroides plebeius improves muscle wasting in chronic kidney disease by modulating the gut-renal muscle axis.J Cell Mol Med. 2022 Dec;26(24):6066-6078. doi: 10.1111/jcmm.17626. Epub 2022 Dec 2. J Cell Mol Med. 2022. PMID: 36458537 Free PMC article.
-
Alterations in the gut microbiome and metabolism profiles reveal the possible molecular mechanism of renal injury induced by hyperuricemia in a mouse model of renal insufficiency.Ren Fail. 2024 Dec;46(2):2387429. doi: 10.1080/0886022X.2024.2387429. Epub 2024 Aug 12. Ren Fail. 2024. PMID: 39132829 Free PMC article.
-
Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy.Front Pharmacol. 2022 Sep 13;13:969930. doi: 10.3389/fphar.2022.969930. eCollection 2022. Front Pharmacol. 2022. PMID: 36176440 Free PMC article. Review.
-
Progress in Pathogenesis of Immunoglobin A Nephropathy.Cureus. 2020 Jun 23;12(6):e8789. doi: 10.7759/cureus.8789. Cureus. 2020. PMID: 32724739 Free PMC article. Review.
References
-
- De Sordi L, Khanna V, Debarbieux L. The gut microbiota facilitates drifts in the genetic diversity and infectivity of bacterial viruses. Cell Host Microbe. 2017;22(801–808):e803. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous